These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 897403)

  • 21. Modification with NaF in disequilibrium of otospongiotic origin.
    Bretlau P; Causse JB; Causse J
    Adv Otorhinolaryngol; 1982; 28():73-9. PubMed ID: 7113821
    [No Abstract]   [Full Text] [Related]  

  • 22. Medical Management of Otosclerosis.
    de Oliveira Penido N; de Oliveira Vicente A
    Otolaryngol Clin North Am; 2018 Apr; 51(2):441-452. PubMed ID: 29502728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Status of hearing in patients with otosclerosis shortly after conservative therapy with sodium fluoride].
    Galochkin VI
    Vestn Otorinolaringol; 1986; (4):34-8. PubMed ID: 3750615
    [No Abstract]   [Full Text] [Related]  

  • 24. Otospongiosis and sodium fluoride. A blind experimental and clinical evaluation of the effect of sodium fluoride treatment in patients with otospongiosis.
    Bretlau P; Causse J; Causse JB; Hansen HJ; Johnsen NJ; Salomon G
    Ann Otol Rhinol Laryngol; 1985; 94(2 Pt 1):103-7. PubMed ID: 3888030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluoride therapy for otosclerosis.
    Shambaugh GE
    Arch Otolaryngol Head Neck Surg; 1990 Oct; 116(10):1217. PubMed ID: 2206512
    [No Abstract]   [Full Text] [Related]  

  • 26. Sodium fluoride as a treatment for otosclerotic hearing loss.
    Linthicum FH; Forquer BD
    Am J Otol; 1985 Jan; 6(1):35-7. PubMed ID: 3976857
    [No Abstract]   [Full Text] [Related]  

  • 27. Otospongiosis: morphologic and microchemical investigation after NaF-treatment.
    Bretlau P; Hansen HJ; Causse J; Causse JB
    Otolaryngol Head Neck Surg; 1981; 89(4):646-50. PubMed ID: 6793977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current status of fluoride therapy for otosclerosis.
    Snow JB
    Am J Otol; 1985 Jan; 6(1):56-8. PubMed ID: 3976859
    [No Abstract]   [Full Text] [Related]  

  • 29. [Importance of histologic examination of footplate pieces to provide an indication for postoperative sodium fluoride. Study of 58 stapedectomies].
    Cura O; Gunhan O; Palandoken M; Olgun L; Oztop F
    Rev Laryngol Otol Rhinol (Bord); 1982; 103(3):203-6. PubMed ID: 7156539
    [No Abstract]   [Full Text] [Related]  

  • 30. Adult fluoride therapy for ostosclerosis (otospongiosis).
    Shambaugh GE
    Arch Otolaryngol; 1983 May; 109(5):353. PubMed ID: 6847492
    [No Abstract]   [Full Text] [Related]  

  • 31. Complications of the fenestration operation and their management.
    Shambaugh GE
    Otolaryngol Clin North Am; 1982 Nov; 15(4):837-43. PubMed ID: 7162821
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of sodium fluoride on otosclerotic activity as determined by strontium.
    Linthicum FH; House HP; Althaus SR
    Ann Otol Rhinol Laryngol; 1973; 82(4):609-15. PubMed ID: 4721187
    [No Abstract]   [Full Text] [Related]  

  • 33. Experimental studies on pathology and therapy of otospongiosis.
    Petrovic AG; Stutzmann JJ; Shambaugh GE
    Am J Otol; 1985 Jan; 6(1):43-50. PubMed ID: 2983562
    [No Abstract]   [Full Text] [Related]  

  • 34. Objective changes in trypsin, alpha 1-antitrypsin, and alpha 2-macroglobulin values as a result of sodium fluoride treatment in patients with otosclerosis.
    Causse JR; Uriel J; Berges J; Bretlau P; Shambaugh GE; Causse JB
    Am J Otol; 1985 Jan; 6(1):38-42. PubMed ID: 2579564
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-term fluoride and calcium therapy of postmenopausal osteoporosis.
    Lie H; Malde K; Sorteberg K; Hasvold O; Ekren T; Malm OJ
    J Oslo City Hosp; 1982 Dec; 32(12):147-54. PubMed ID: 7153813
    [No Abstract]   [Full Text] [Related]  

  • 36. [Juvenile otosclerosis].
    Sicard F; Desjardins R
    Union Med Can; 1970 Sep; 99(9):1639-41. PubMed ID: 5527441
    [No Abstract]   [Full Text] [Related]  

  • 37. Otosclerosis 1981 to 1985. Our four-year review and current perspective.
    Wiet RJ; Raslan W; Shambaugh GE
    Am J Otol; 1986 May; 7(3):221-8. PubMed ID: 3521305
    [No Abstract]   [Full Text] [Related]  

  • 38. Mixed hearing loss in otosclerosis: indication for long-term follow-up.
    Ramsay HA; Linthicum FH
    Am J Otol; 1994 Jul; 15(4):536-9. PubMed ID: 8588610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluoride therapy for otosclerosis.
    Kerr GS; Hoffman GS
    Ear Nose Throat J; 1989 Jun; 68(6):426, 428-9. PubMed ID: 2663438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluorides for otospongiosis and other osteoporotic states.
    Shambaugh GE
    Ann Otolaryngol Chir Cervicofac; 1973 Mar; 90(3):129-38. PubMed ID: 4717369
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.